R&D Systems™ Recombinant Human TMED1 Fc Chimera Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human TMED1 Fc Chimera Protein is derived from HEK293. The Recombinant Human TMED1 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q13445
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 11018
• Molecular Weight (g/mol): 46 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived human TMED1 protein, (N-terminus) Human TMED1 (Ala24-Asn194) Accession &Num; Q13445 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: TMED1
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.